Role of proton receptor OGR1 in bone response to metabolic acidosis?. Jorgetti, Vanda; Drüeke, Tilman B.; Ott, Susan M.. Kidney International. 2016; 89: p.529-531. doi:10.1016/j.kint.2015.12.031Article
Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts. Harding, Jessica L.; Sooriyakumaran, Manoshayini; Anstey, Kaarin J.; Adams, Robert; Balkau, Beverley; Brennan-Olsen, Sharon; Briffa, Tom; Davis, Timothy M. E.; Davis, Wendy A.; Dobson, Annette; Giles, Graham G.; Grant, Janet; Huxley, Rachel; Knuiman, Matthew; Luszcz, Mary; Mitchell, Paul; Pasco, Julie A.; Reid, Christopher M.; Simmons, David; Simons, Leon A.; Taylor, Anne W.; Tonkin, Andrew; Woodward, Mark; Shaw, Jonathan E.; Magliano, Dianna J.. Journal of Hypertension. 2016; 34: p.149-155. doi:10.1097/HJH.0000000000000770Article
Complications rénales chroniques à long termes chez les survivants de cancer. Mansouri Imène. []: Paris Sud; 2016. Thesis
Les conditions d’une autonomie de l’éthique. Coutellec, Léo. Revue française d'éthique appliquée. 2016; N° 2: p.11. doi:10.3917/rfeap.002.0011Article
Psychiatric and substance use disorders in HIV/hepatitis C virus (HCV)-coinfected patients: does HCV clearance matter? [Agence Nationale de Recherche sur le SIDA et les Hépatites Virales (ANRS) HEPAVIH CO13 cohort]. Michel, L.; Lions, C.; Winnock, M.; Lang, J.P.; Loko, M.A.; Rosenthal, E.; Marchou, B.; Valantin, M.A.; Morlat, P.; Roux, P.; Sogni, P.; Spire, B.; Poizot-Martin, I.; Lacombe, K.; Lascoux-Combe, C.; Duvivier, C.; Neau, D.; Dabis, F.; Salmon-Ceron, D.; Carrieri, M.P.; A.N.R.S. H.E.P.A.V.I.H. CO13 study group.. HIV Med. 2016; 17: p.758–765. doi:doi: 10.1111/hiv.12382Article
Reliability and validity of the French version of the global physical activity questionnaire. Rivière, Fabien; Widad, Fatima Zahra; Speyer, Elodie; Erpelding, Marie-Line; Escalon, Hélène; Vuillemin, Anne. Journal of Sport and Health Science. 2016; : . doi:10.1016/j.jshs.2016.08.004Article
Postoperative radiotherapy for non-small cell lung cancer. Burdett, S.; Rydzewska, L.; Tierney, J.; Fisher, D.; Parmar, M. K.; Arriagada, R.; Pignon, J. P.; Le Pechoux, C.; Group, Port Meta-analysis Trialists. Cochrane Database Syst Rev. 2016; CD002142: p.CD002142. doi:10.1002/14651858.CD002142.pub4 10.1002/14651858.CD002142.pub4.Article
Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial. Jovelet, C.; Ileana, E.; Le Deley, M. C.; Motte, N.; Rosellini, S.; Romero, A.; Lefebvre, C.; Pedrero, M.; Pata-Merci, N.; Droin, N.; Deloger, M.; Massard, C.; Hollebecque, A.; Ferte, C.; Boichard, A.; Postel-Vinay, S.; Ngo-Camus, M.; De Baere, T.; Vielh, P.; Scoazec, J. Y.; Vassal, G.; Eggermont, A.; Andre, F.; Soria, J. C.; Lacroix, L.. Clin Cancer Res. 2016; 2960-8: p.2960-8. doi:10.1158/1078-0432.CCR-15-2470 10.1158/1078-0432.CCR-15-2470. Epub 2016 Jan 12.Article
Uncovering Professional Attitudes Toward Treatment of Rare Carcinomas of the Breast: An International Practice e-Survey Involving 32 Countries. Saghatchian, M.; Fadoukhair, Z.; Hofert, K.; Lanoy, E.; Mathieu, M. C.; Mazouni, C.; Delaloge, S.. Breast J. 2016; 96-100: p.96-100. doi:10.1111/tbj.12525 10.1111/tbj.12525. Epub 2015 Oct 28.Article
New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation study. Bayar, M. A.; Le Teuff, G.; Michiels, S.; Sargent, D. J.; Le Deley, M. C.. Stat Med. 2016; 3245-58: p.3245-58. doi:10.1002/sim.6942 10.1002/sim.6942. Epub 2016 Mar 30.Article